Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

[1] Albert MS(2011)The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease Alzheimers Dement 7 270-279

[2] DeKosky ST(2021)2021 Alzheimer’s disease facts and figures Alzheimers Dement 17 327-406

[3] Dickson D(2015)Mini-mental state examination (MMSE) for the detection of Alzheimer’s disease and other dementias in people with mild cognitive impairment (MCI) Cochrane Database Syst Rev 50 229-237

[4] Arevalo-Rodriguez I(2006)Prostaglandin D2 mediates neuronal damage by amyloid-beta or prions which activates microglial cells Neuropharmacology 29 263-271

[5] Smailagic N(2006)Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors Trends Neurosci 48 4866-211

[6] Roqué I(2007)Homeostatic Regulation of Photoreceptor Cell Integrity: Significance of the Potent Mediator Neuroprotectin D1 Biosynthesized from Docosahexaenoic Acid The Proctor Lecture Investig Ophthalmol Vis Sci 81 205-327

[7] Figuls M(2009)Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection Prostaglandins Leukot Essent Fatty Acids 40 315-420

[8] Bate C(2014)Proresolving lipid mediators and mechanisms in the resolution of acute inflammation Immunity 88 411-174

[9] Kempster S(2002)Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women Br J Nutr 59 169-88

[10] Williams A(1986)Prostaglandin E2 and fever: a continuing debate Yale J Biol Med 77 85-903

[1] Albert MS(2011)The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease Alzheimers Dement 7 270-279

[2] DeKosky ST(2021)2021 Alzheimer’s disease facts and figures Alzheimers Dement 17 327-406

[3] Dickson D(2015)Mini-mental state examination (MMSE) for the detection of Alzheimer’s disease and other dementias in people with mild cognitive impairment (MCI) Cochrane Database Syst Rev 50 229-237

[4] Arevalo-Rodriguez I(2006)Prostaglandin D2 mediates neuronal damage by amyloid-beta or prions which activates microglial cells Neuropharmacology 29 263-271

[5] Smailagic N(2006)Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors Trends Neurosci 48 4866-211

[6] Roqué I(2007)Homeostatic Regulation of Photoreceptor Cell Integrity: Significance of the Potent Mediator Neuroprotectin D1 Biosynthesized from Docosahexaenoic Acid The Proctor Lecture Investig Ophthalmol Vis Sci 81 205-327

[7] Figuls M(2009)Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection Prostaglandins Leukot Essent Fatty Acids 40 315-420

[8] Bate C(2014)Proresolving lipid mediators and mechanisms in the resolution of acute inflammation Immunity 88 411-174

[9] Kempster S(2002)Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women Br J Nutr 59 169-88

[10] Williams A(1986)Prostaglandin E2 and fever: a continuing debate Yale J Biol Med 77 85-903